Section Arrow
CDXC.NASDAQ
- ChromaDex Corp
Quotes are at least 15-min delayed:2024/05/16 15:16 EDT
Last
 3.48
-0.15 (-4.13%)
Day High 
3.68 
Prev. Close
3.63 
1-M High
4.18 
Volume 
144.24K 
Bid
3.47
Ask
3.49
Day Low
3.465 
Open
3.62 
1-M Low
2.89 
Market Cap 
274.21M 
Currency USD 
P/E -- 
%Yield
10-SMA 3.65 
20-SMA 3.57 
50-SMA 3.37 
52-W High 4.65 
52-W Low 1.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.05/0.06
Enterprise Value
276.78M
Balance Sheet
Book Value Per Share
0.38
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
83.57M
Operating Revenue Per Share
1.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1+0.0223+28.70%-- 
NBYNovaBay Pharmaceuticals0.1204+0.0159+15.22%-- 
DNAGinkgo Bioworks Holdings0.8334-0.0057-0.68%-- 
JAGXJaguar Health0.2866+0.0315+12.35%-- 
NVAXNovavax14.22+1.32+10.23%-- 
Quotes are at least 15-min delayed:2024/05/16 15:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.